United States Providers

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

11/3/2026, 12:59:00 AM

EXECUTIVE SUMMARY

A deceleration in U.S. commercial contract growth gave some Wall Street analysts pause despite Palantir’s earnings beat.

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter.
A deceleration in U.S.
commercial contract growth gave some Wall Street analysts pause despite Palantir’s earnings beat.

A deceleration in U.S. commercial contract growth gave some Wall Street analysts pause despite Palantir’s earnings beat.

Published originally on MarketWatch Top Stories

🇺🇸 United States

Finance & Markets1h ago

Although iPhone demand remains strong, Apple faces a worsening memory crunch and a slowing services business.

MarketWatch Top Stories

Finance & Markets1h ago

The “tech wreck” from October continues. Is a bear market next?

MarketWatch Top Stories

Finance & Markets2h ago

Shares of both companies fell Monday after Marvell said it reached an all-stock agreement to buy Lumentum.

MarketWatch Top Stories

Finance & Markets3h ago

Some investors appeared a little too eager to buy the dip in technology stocks last month.

MarketWatch Top Stories

Multikhabar App

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!